Plasma exchange successfully treated macrophage activation syndrome in rheumatoid factor-positive polyarticular

Lianjie Shi1,2, Fanlei Hu3, Chuanhui Xu4

  • 1Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China.

Insights

Plasma exchange effectively treated macrophage activation syndrome (MAS) in a young patient with rheumatoid factor-positive polyarticular juvenile idiopathic arthritis (JIA) and pneumonia. This intervention led to a complete recovery within one week.

Area of Science:

  • Rheumatology
  • Pediatrics
  • Critical Care Medicine

Background:

  • Macrophage activation syndrome (MAS) is a severe complication of rheumatic diseases, particularly systemic juvenile idiopathic arthritis (sJIA).
  • MAS presents a diagnostic and therapeutic challenge, especially in atypical presentations.
  • Early recognition and effective treatment are crucial for patient outcomes.

Purpose of the Study:

  • To report a case of successful plasma exchange in a patient with RF-positive polyarticular JIA and MAS.
  • To highlight an alternative treatment approach for refractory MAS in pediatric patients.
  • To discuss the management of MAS in the context of concurrent pneumonia.

Main Methods:

  • A 9-year-old female with RF-positive polyarticular JIA presented with MAS and pneumonia.
  • Initial treatments including antibiotics, methylprednisolone, cyclosporine A, and IVIG failed to improve symptoms.
  • Plasma exchange was initiated, administered every other day for a total of three sessions.

Main Results:

  • The patient exhibited typical MAS laboratory findings, including elevated liver enzymes, ferritin, and PCT, with decreased NK cells and fibrinogen.
  • Chest CT confirmed pneumonia, complicating the clinical picture.
  • Following plasma exchange, the patient experienced complete clinical and laboratory recovery from MAS within one week.

Conclusions:

  • Plasma exchange can be a highly effective rescue therapy for MAS, even in complex cases involving concurrent infections.
  • This case expands the therapeutic options for MAS in pediatric rheumatology.
  • Prompt and aggressive management, including considering advanced therapies like plasma exchange, is vital for refractory MAS.